The family and friends of Susan B. Lester endowed a lectureship in her honor, and it is this generous donation that makes the Markey Cancer Center Research Day possible.
Mrs. Lester left an indelible mark on her world, serving as a clinical dietician for Eastern State Hospital and for nursing home patients in Eastern and Central Kentucky.
This symposium benchmarks recent advances in cancer research and thus honors Mrs. Lester by underscoring both her generous life and the brave battle she fought against this disease.
Questions? Contact the event coordinator via e-mail: email@example.com
Douglas R. Lowy, MD
Principal Deputy Director, National Cancer Institute
Chief, Laboratory of Cellular Oncology
NIH Distinguished Investigator
Head, Signaling and Oncogenesis Section
Dr. Lowy currently serves as Acting Director of the National Cancer Institute. As Laboratory Chief, Dr. Lowy’s two main research areas focus on basic and translational aspects of human papillomavirus infection and on cancer genes. His joint research with John Schiller has identified many aspects of the human papillomavirus (HPV) life cycle, developed technology underlying the FDA-approved HPV vaccines, and elucidated mechanisms for the high efficacy of the vaccines. His joint research with John Schiller in the Laboratory of Cellular Oncology (LCO) has identified many aspects of the HPV life cycle, developed technology underlying the FDA-approved HPV vaccines, and elucidated mechanisms for the high efficacy of the vaccines. Secondly, his research is currently examining the DLC1 tumor suppressor, which encodes a Rho-GAP that is down-regulated in a wide variety of cancers, leading to the high Rho activity seen in many advanced cancers. This research has identified important scaffold functions for DLC1, including protein-protein interactions that contribute to the regulation of its activity and its role as a tumor suppressor, and identified kinases that activate and inactivate the functions of DLC1 and the mechanisms by which they do so.
In 1983, Dr. Friedell became the first director of the UK Markey Cancer Center, beginning a legacy of cancer care that continues to grow and make a difference in the lives of Kentuckians every day. At Markey, he co-founded the Kentucky Cancer Registry – now one of the premiere SEER databases in the country – and served as the principal investigator of the National Cancer Institute’s Mid-South Cancer Information Service, a cancer education program that provides easy-to-understand information for cancer patients, survivors, health care providers and more.
Dr. Friedell was a passionate advocate for programs that provided education and increased access to healthcare for the medically underserved, particularly in Appalachian Kentucky. He famously believed that “If the problems are in the community, the solutions are in the community.” With this in mind, he helped launch Kentucky Homeplace, an initiative that has linked tens of thousands of rural Kentuckians with medical, social and environmental services since it began in 1994.
Though he retired from UK in 2000, Dr. Friedell’s influence is still felt strongly in the overarching mission of our cancer center: to conquer cancer in the Commonwealth. We at Markey are proud to uphold the vision and values of Dr. Friedell, building upon his contributions to public health as we continue to care for Kentuckians with cancer.
Gilbert H. Friedell, MD, Memorial Lecture
Edward E. Partridge, MD
Director, University of Alabama at Birmingham
Dr. Partridge is currently the Director of the UAB Comprehensive Cancer Center, a center with a long and rich history addressing issues of cancer disparities through research and service in both rural and inner-city underserved communities. His cancer control research is focused on health disparities. He currently serves as PI for the Deep South Cancer Control Network, addressing age-appropriate screening, healthy eating and physical activity in traditionally underserved, rural and inter-city African American populations in Alabama and Mississippi. He previously served as PI and is the current Co-PI of the Morehouse School of Medicine/Tuskegee University/UAB Comprehensive Cancer Center Partnership, which conducts both basic and applied research in cancer disparities and focuses on training of minority investigators. He is also the PI of the partnership with Johns Hopkins for a Cervical Specialized Progress of Research Excellence (SPORE) and previously served as PI for the Ovarian SPORE at UAB. He recently was awarded a large grant from Centers for Medicare and Medicaid Services to study the utilization of lay navigators across the UAB Cancer Care Network and across the continuum of disease through treatment, survivorship and end of life. Through his leadership of the Mid-South Division of the American Cancer Society, where he served as Chairman, ACS has focused on reducing and eliminating cancer disparities. As President of the American Cancer Society National Board of Directors, he provided leadership for the development of mission priorities that address cancer disparities.
NOTICE: To protect the health of our attendees – and to follow the novel coronavirus (COVID-19) guidelines implemented by national, state and local governments – the Markey Cancer Center Research Day (MCCRD) 2020 scheduled for May 6th has been canceled.
8:45 – 9:30 Student talks
9:30 – 10:30 Faculty talks
10:30 – 11:45 Poster presentation #1
11:30 – 1:00 Lunch break/Exhibit Hall
12:15 – 1:30 Poster presentation #2
1:30 – 1:50 “State of the Cancer Center,” by Dr. Mark Evers
1:50 – 2:45 Gilbert H. Friedell, MD, Memorial Lecture by Dr. Edward Partridge
2:45 – 3:00 Break
3:00 – 3:10 Markey Women Strong Awards and Patient Presentation by Markey Cancer Foundation
3:10 – 4:05 Susan B. Lester Memorial Lecture by Dr. Douglas Lowy
4:05 – 4:15 Awards Presentation
The poster presentation is held in two sessions. Detailed instructions are e-mailed to authors of accepted abstracts. The following guidelines are to be followed for posters:
- Abstracts are limited to 525 words or less.
- Tables and illustrations should be kept relatively simple.
- Type size, lines and symbols in illustrations should be sufficiently large and bold to be comprehensible from a viewing distance of up to 6 feet.
- Each poster should contain a top panel containing the title of the abstract and the names of authors.
- Illustrative material should be arranged in a logical order from top down and left-to-right.
- The poster board assigned to each presenter has a usable area of 8 feet in width and 4 feet in height.
- Pushpins will be provided.
One graduate student, one post-doctoral fellow and one junior faculty will be invited to give oral presentations at the event.
Visit the Call for Abstracts/Poster Submission Form online
Contact the event coordinator via email at firstname.lastname@example.org.